Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Smouldering multiple sclerosis: the 'real MS'.
Giovannoni G, Popescu V, Wuerfel J, Hellwig K, Iacobaeus E, Jensen MB, García-Domínguez JM, Sousa L, De Rossi N, Hupperts R, Fenu G, Bodini B, Kuusisto HM, Stankoff B, Lycke J, Airas L, Granziera C, Scalfari A. Giovannoni G, et al. Among authors: scalfari a. Ther Adv Neurol Disord. 2022 Jan 25;15:17562864211066751. doi: 10.1177/17562864211066751. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 35096143 Free PMC article. Review.
Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.
Young CA, Chaouch A, Mcdermott CJ, Al-Chalabi A, Chhetri SK, Talbot K, Harrower T, Orrell RW, Annadale J, Hanemann CO, Scalfari A, Tennant A, Mills R; TONIC-ALS STUDY GROUP. Young CA, et al. Among authors: scalfari a. Amyotroph Lateral Scler Frontotemporal Degener. 2024 Aug;25(5-6):475-485. doi: 10.1080/21678421.2024.2322545. Epub 2024 Mar 11. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 38465877 Free PMC article.
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients.
Allen-Philbey K, De Trane S, Mao Z, Álvarez-González C, Mathews J, MacDougall A, Stennett A, Zhou X, Yildiz O, Adams A, Bianchi L, Blain C, Chapman C, Chung K, Constantinescu CS, Dalton C, Farrell RA, Fisniku L, Ford H, Gran B, Hobart J, Khaleeli Z, Mattoscio M, Pavitt S, Pearson O, Peruzzotti-Jametti L, Scalfari A, Sharrack B, Silber E, Tallantyre EC, Webb S, Turner BP, Marta M, Gnanapavan S, Juliusson G, Giovannoni G, Baker D, Schmierer K. Allen-Philbey K, et al. Among authors: scalfari a. Ther Adv Neurol Disord. 2021 Nov 25;14:17562864211057661. doi: 10.1177/17562864211057661. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 35173808 Free PMC article.
MS care: integrating advanced therapies and holistic management.
Giovannoni G, Ford HL, Schmierer K, Middleton R, Stennett AM, Pomeroy I, Fisniku L, Scalfari A, Bannon C, Stross R, Hughes S, Williams A, Josephs S, Peel C, Straukiene A. Giovannoni G, et al. Among authors: scalfari a. Front Neurol. 2024 Jan 30;14:1286122. doi: 10.3389/fneur.2023.1286122. eCollection 2023. Front Neurol. 2024. PMID: 38351950 Free PMC article. Review.
Smouldering-Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions.
Scalfari A, Traboulsee A, Oh J, Airas L, Bittner S, Calabrese M, Garcia Dominguez JM, Granziera C, Greenberg B, Hellwig K, Illes Z, Lycke J, Popescu V, Bagnato F, Giovannoni G. Scalfari A, et al. Ann Neurol. 2024 Nov;96(5):826-845. doi: 10.1002/ana.27034. Epub 2024 Jul 25. Ann Neurol. 2024. PMID: 39051525 Review.
51 results